Epilepsy :: Implantable device designed to detect, stop seizures under study at MCG
Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.
logo - spiritindia - Epilepsy :: Implantable device designed to detect, stop seizures under study at MCG
GMP-certified manufacturing consultant

Implantable device designed to detect, stop seizures under study at MCG

Epilepsy :: Implantable device designed to detect, stop seizures under study at MCG

Epilepsy :: Implantable device designed to detect, stop seizures under study at MCG

A small device implanted in the skull that detects oncoming seizures, then delivers a brief electrical stimulus to the brain to stop them is under study at the Medical College of Georgia.

MCG is among 28 U.S. centers participating in a study to determine if the neurostimulator device can help patients whose seizures are not well controlled by drugs.

?The device constantly monitors electrical activity of the brain, gets accustomed to what is normal for that patient and, when it detects activity that is abnormal, within a few milliseconds, sends out a small electrical stimulus to stop it,? says Dr. Yong Park, MCG pediatric epileptologist and a principal investigator.

At MCG Medical Center, the RNS? System, developed by California-based medical device manufacturer NeuroPace, will be used in about 10 patients age 18-70 who have failed to get their seizures controlled with at least two medications. About 240 patients are expected to enroll nationwide.

Eligible participants must have at least three seizures per month and no more than two seizure foci in the brain. Seizure activity is closely monitored through a diary and monthly doctor visits for three months before patients become eligible.

Participants have a device implanted in the skull, with up to two wires containing electrodes placed near the seizure focus. A modified laptop computer looks at electrical activity picked up by the neurostimulator, then is used to program the device to recognize a patient?s seizure activity. Physicians can continue to fine-tune the detection and stimulation patterns.

During the first month after implant, the RNS? is set for detection only while doctors design a set of parameters that allow it to reliably detect the onset of seizure activity, says Dr. Patty Ray, study coordinator. After one month, half of the patients are set for detection and responsive stimulation, the other half continue with detection only. After four months, all devices are set for detection and responsive stimulation throughout the remainder of the two-year study. After the study, patients will be eligible for a study to continue to use the device until it receives FDA approval, Dr. Ray says.

Participants remain on anti-seizure medication throughout the study, although Dr. Park suspects some patients may eventually be weaned off drugs. During this study, researchers also are collecting data on which drugs work best with the neurostimulator.

MCG participated in a smaller feasibility study of the neurostimulator in 2004 and prior to that was among the first centers in the country to use it as an external, temporary measure to try to stop seizures in hospitalized patients whose seizure activity was being monitored, Dr. Park says.

About 1 in 200 people have seizures and about 1 out of 3 cannot get seizures under control with one or more medications. Some people are not candidates for traditional epilepsy surgery to remove the seizure focus because the location increases the risk of problems or deficits, because there are too many foci or because they simply do not want the surgery, Dr. Park says. Early evidence indicates the RNS? device might be most effective for foci in the medial temporal lobe, an area deep inside the brain involved in memory, where surgery is not an option, he says.

A handful of new drugs, with generally fewer side effects, also have become available in the last few years, giving patients and their doctors more options, he says. MCG has begun studies of three additional anti-seizure medications.

Also on the horizon is a mechanism that delivers a bolus of drug directly to the seizure focus in the brain, which may enhance efficacy and decrease side effects, as well as gene therapy to modify abnormal brain tissue, says Dr. Park, who wants MCG to participate when those studies move to clinical trials.




(Epilepsy :: Implantable device designed to detect, stop seizures under study at MCG published at SpiritIndia on Monday, September 10, 2007)



Epilepsy

Search more information on Epilepsy, Epilepsy books

Recently posted related articles on Epilepsy :

  1. Epilepsy :: Reports of seizure frequency may be inaccurate in patients with focal epilepsy
  2. Epilepsy :: Once-a-day epilepsy drug is effective for partial seizures
  3. Epilepsy :: FDA approves first generic anticonvulsant drug Trileptal
  4. Epilepsy :: Research shows how genetic mutation causes epilepsy in infants
  5. Epilepsy :: GSK's Lamictal extended-release tablets for epilepsy
  6. Epilepsy :: Study of New Epilepsy Treatment Underway at URMC
  7. Epilepsy :: Implantable device designed to detect, stop seizures under study at MCG
  8. Epilepsy :: Ovation further advances development pipeline with new phase III epilepsy study
  9. Epilepsy :: Experiencing auras? You may be a good candidate for epilepsy surgery
  10. Epilepsy :: Miniature implanted devices could treat epilepsy, glaucoma

Most related articles:

- Epilepsy :: Implantable device designed to detect, stop seizures under study at MCG
- Epilepsy :: Study of New Epilepsy Treatment Underway at URMC - 17.2
- Epilepsy :: Brain implant being studied at Jefferson could predict and stop epilepsy seizures - 16.7
- Epilepsy :: Wake Forest University Baptist Medical Center To Test New Epilepsy Treatment - 15.7
- Epilepsy :: Mass General Hospital testing new epilepsy therapy device - 13.3
- Epilepsy :: Repeated epilepsy seizures harmful - 12
- Epilepsy :: Heat spreader for epileptic seizure treatment device - 11.2
- Epilepsy :: After epilepsy surgery, quality of life related more to seizures than memory - 11
- Epilepsy :: Chinese tile game Mahjong can induce epilepsy - 11
- Brushing :: Does tooth-brushing cause epilepsy seizures? - 10.8


Epilepsy - recent related articles/news stories:

- Sabril to treat spasms in infants and epileptic seizures approved in US
- Epilepsy drug valproate during pregnancy lowers child's IQ
- Epilepsy drug topiramate during pregnancy raises birth defects risk
- Oxcarbazepine doesn't help prevent migraine after all
- Suicidal thoughts and behaviours from epilepsy drugs, alerts Medsafe

»»   Vitamin D :: Vitamin D supplements lower risk of death
««   Leukemia :: Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas






Tools
Daily calorie need
Homeo tips
Homeo softwares
Associations
NHMC Alumni
IFH
PHS
Vital Informer
Articles & news
Education
Homeo articles
Homeopathy cases
Homeopathic Remedies
You
Authors
Submit article
Your account
Testimonials
About
About us
Advertisers
Advertising
Linking us
Disclaimer
Privacy policy

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com